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Selected elements of herpes simplex virus accessory factor HCF
are highly conserved in Caenorhabditis elegans
Abstract
HCF is a mammalian nuclear protein that undergoes proteolytic processing and is required for cell
proliferation. During productive herpes simplex virus (HSV) infection, the viral transactivator VP16
associates with HCF to initiate HSV gene transcription. Here, we show that the worm Caenorhabditis
elegans possesses a functional homolog of mammalian HCF that can associate with and activate the
viral protein VP16. The pattern of sequence conservation, however, is uneven. Sequences required for
mammalian HCF processing are not present in C. elegans HCF. Furthermore, not all elements of
mammalian HCF that are required for promoting cell proliferation are conserved. Nevertheless,
unexpectedly, C. elegans HCF can promote mammalian cell proliferation because a region of HCF that
is conserved can promote mammalian cell proliferation better than its human counterpart. These results
suggest that HCF possesses a highly conserved role in metazoan cell proliferation which is targeted by
VP16 to regulate HSV infection. The precise mechanisms, however, by which HCF functions in
mammals and worms appear to differ.
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HCF is a mammalian nuclear protein that undergoes proteolytic processing and is required for cell
proliferation. During productive herpes simplex virus (HSV) infection, the viral transactivator VP16 associates
with HCF to initiate HSV gene transcription. Here, we show that the worm Caenorhabditis elegans possesses a
functional homolog of mammalian HCF that can associate with and activate the viral protein VP16. The
pattern of sequence conservation, however, is uneven. Sequences required for mammalian HCF processing are
not present in C. elegans HCF. Furthermore, not all elements of mammalian HCF that are required for
promoting cell proliferation are conserved. Nevertheless, unexpectedly, C. elegans HCF can promote mamma-
lian cell proliferation because a region of HCF that is conserved can promote mammalian cell proliferation
better than its human counterpart. These results suggest that HCF possesses a highly conserved role in
metazoan cell proliferation which is targeted by VP16 to regulate HSV infection. The precise mechanisms,
however, by which HCF functions in mammals and worms appear to differ.
In infected cells, human herpes simplex virus (HSV) can
cause either lytic or latent infection. During lytic infection, the
viral regulatory protein VP16 (also referred to as Vmw65,
a-TIF, and ICP25) forms a multiprotein-DNA complex with
two cellular proteins: the POU homeodomain transcription
factor Oct-1 and the cell proliferation factor HCF. VP16 first
associates with HCF (also referred to as C1, VCAF, and CFF)
to form a stable DNA-independent heterodimeric complex.
VP16 binding to HCF facilitates its subsequent association
with Oct-1 on VP16-responsive cis-regulatory TAATGARAT
(R, purine) elements in the HSV immediate-early promoters,
initiating a cascade of viral gene expression (for reviews, see
references 22, 28, and 31).
Human HCF consists of a complex of noncovalently associ-
ated polypeptides ranging from 110 to 150 kDa (15, 16, 30, 32).
These associated polypeptides are derived from a large pre-
cursor protein of over 2,000 amino acids by specific proteolytic
cleavage at a series of six centrally located 26-amino acid re-
peats, referred to here as HCFPRO repeats (15, 30, 32). The
function of the carboxy-terminal fragments is not known.
Within the amino-terminal fragments, however, the amino-
terminal 380 residues are sufficient to bind VP16, stabilize the
VP16-induced complex with Oct-1, and activate transcription
in vivo (17, 33). This region of HCF, called the HCFVIC do-
main, contains six sequence repeats related to “kelch” repeats
found in the Drosophila egg chamber protein kelch (34). These
repeats, called HCFKEL repeats, are both necessary and suffi-
cient for efficient complex formation with VP16 (33). Among
mammalian HCFs, both sets of repeats, HCFPRO and
HCFKEL, are highly conserved (8, 13, 30).
In addition to its role in HSV gene expression, HCF is
required for cell proliferation. A single missense mutation in
the hamster cell line tsBN67, a proline-to-serine substitution at
position 134 (P134S) of HCF, causes a temperature-sensitive
defect in cell proliferation (8) and disrupts interaction with
VP16 (33). Consistent with an involvement in cell prolifera-
tion, human HCF is expressed in proliferating cultured cells
and embryonic tissues (13, 29).
HCF may have been conserved during metazoan evolution,
because extracts from Spodoptera and Drosophila insect cells,
but not yeast, can stabilize VP16 association with human Oct-1
(14, 31). We show here that the nematode Caenorhabditis
elegans expresses a functional homolog of human HCF. Al-
though C. elegans HCF lacks some sequence elements impor-
tant for human HCF function, the C. elegans HCF homolog
can support mammalian cell proliferation, suggesting that
HCF plays a highly conserved role in metazoan cell prolifera-
tion.
MATERIALS AND METHODS
Extract preparation and electrophoretic mobility retardation analysis. Wild-
type Bristol N2 strain C. elegans worms were grown as previously described (4).
All worms were grown at 20°C. Worms were freed of bacteria (18) and collected,
and worm pellets were suspended in 10 mM HEPES (pH 7.6) containing 10 mM
KCl, 5 mM MgCl2, 0.1 mM EDTA, 0.5 mM EGTA, 10 mM benzamidine, 1 mM
Na metabisulfite, 2 mg of leupeptin/ml, and 2 mg of aprotinin/ml. The worm
suspension was passed through a French press at 1,500 psi. The homogenate was
then centrifuged at 85,000 3 g for 30 min at 4°C. The supernatant solution was
taken as total cell extract. About 2 mg of cell extract (about 1 to 3 mg/ml) was used
for electrophoretic mobility retardation analysis. Human HCF was purified by
immunoprecipitation with amino-terminal aHCFN18 antipeptide antisera (8) and
elution with the HCFN18 peptide. The Oct-1 POU domain and VP16 lacking its
transcriptional activation domain (VP16DC) were prepared for VP16-induced
complex formation as glutathione S-transferase (GST) fusion proteins. The pro-
teins were expressed and purified from Escherichia coli as previously described
(30, 33); the Oct-1 POU domain, but not VP16DC, was separated from the GST
moiety by treatment with thrombin. Electrophoretic mobility retardation analysis
was performed with the (OCTA1)TAATGARAT probe as previously described
(30).
C. elegans hcf-1 cDNA isolation and in vitro protein expression. The amino
acid sequence of the human HCFVIC domain (residues 1 to 380) was used to
search the C. elegans Sanger Center Network database (26) with TBLASTN (2).
Significant sequence similarity to a predicted gene present on the overlapping
cosmids C33H5 and C46A5 was found. A cDNA copy of this gene was prepared
by PCR with oligonucleotides containing C. elegans sequence corresponding to
predicted initiation (ATGGACGAAGATGTCGGTTTAG) and termination
(TTACTGATGATCGAAACGAGCTC) codons (underlined) and a mixed-
stage C. elegans cDNA library (a kind gift of R. Barstead, Oklahoma Medical
Research Foundation). A 2.4-kb DNA fragment was amplified and isolated for
sequence analysis and subcloning. Sequences encoding the full-length (782 res-
idues) and the amino-terminal 395 amino acids of C. elegans HCF were cloned
into the in vitro transcription and translation expression plasmid pNCITE as
previously described (33). In vitro transcription and translation reactions were
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performed with the TNT system (Promega, Inc.). The anti-C. elegans HCF
antiserum aCeHCFN16 was raised in rabbits against a 17-amino-acid peptide
containing the 16 amino-terminal residues of C. elegans HCF (MDEDVGLEA
TNYSRGDC) (underlined) coupled to keyhole limpet hemocyanin via the car-
boxy-terminal cysteine residue as previously described (10).
Synchronization of C. elegans, extract preparation, and Northern hybridiza-
tion analysis. Viable Bristol N2 strain C. elegans embryos were prepared by
treating a mixed population of worms with alkaline hypochlorite (11). The
embryos were synchronized by letting the worms hatch in the absence of nutri-
ents at 20°C overnight. The hatched worms were subsequently transferred to
NGM plates with E. coli OP50 as a food source. L1-stage worms were harvested
6 h after feeding; the harvesting times (hours) after feeding for worms at other
stages were as follows: L2, 20; L3, 29; L4, 40 h. Young adult worms were
harvested 52 h after feeding (18). The stage of worm development was verified
by microscopic examination. Protein extracts were prepared and electrophoretic
mobility retardation analyses were performed as described above. RNA extracts
were prepared from cleaned worms by freezing the pelleted worms in liquid
nitrogen and grinding them into a powder in a mortar for total RNA preparation
as previously described (12). Twenty-five micrograms of total RNA was used to
perform Northern hybridization analysis as previously described (23) with 32P-
labeled, random-primed DNA fragments corresponding to full-length C. elegans
hcf-1 as the probe.
Mammalian-cell HCF expression vectors and rescue of the tsBN67 tempera-
ture-sensitive defect. The human HCF expression constructs pCGNHCFFL,
pCGNHCFN1011, and pCGNHCFN380 have been described previously (30, 33).
The C. elegans HCF expression constructs pCGNCeHCFFL and pCGNCeH-
CFN395 contain coding sequences corresponding to full-length HCF and the
amino-terminal 395 residues of CeHCF, respectively, in the cytomegalovirus
promoter and hemagglutinin epitope-tagged expression construct pCGN (30).
Rescue of the tsBN67 temperature-sensitive defect was performed as described
previously (8). tsBN67 cells were seeded at 2 3 105 cells/100-mm-diameter dish
and cultured in Dulbecco’s modified Eagle medium supplemented with 10%
fetal bovine serum at permissive temperature (33.5°C) for 20 h prior to trans-
fection. Expression constructs for human or C. elegans HCF (2 mg/dish) were
then cotransfected by calcium-phosphate coprecipitation with the plasmid
pSV2neo (0.5 mg/dish) into tsBN67 cells (5). Following transfection, the cells
were incubated at 33.5°C for 20 h, washed with serum-free medium, and incu-
bated at 33.5°C for an additional 24 h before selection for 2 weeks at the
nonpermissive temperature of 39.5°C in the presence of G418 (0.8 mg/ml).
Colonies were identified by fixation and staining with crystal violet.
Nucleotide sequence accession number. The GenBank accession number for
the C. elegans HCF sequence is AF072907.
RESULTS
VP16-induced complex-forming activity in C. elegans ex-
tracts. Analyses of insect cells have revealed an activity capable
of stabilizing VP16 association with human Oct-1, suggesting
the existence of an HCF homolog in insects (14, 31). To de-
termine whether such an activity is generally present in meta-
zoans, we asked whether extracts from the nematode C. elegans
can also stabilize VP16 association with human Oct-1, as
shown in Fig. 1. We prepared cell extract from mixed-stage
worms and compared the VP16-induced complex formation of
this extract with that of purified human HCF by using an
electrophoretic mobility retardation assay with an HSV TAA
TGARAT site. The TAATGARAT site, an (OCTA1)TAAT
GARAT site, contained the octamer sequence ATGCTAAT,
which serves as a binding site for Oct-1. For this assay, we used
VP16 lacking its transcriptional-activation domain and the hu-
man Oct-1 DNA-binding POU domain expressed and purified
from E. coli. In the absence of human HCF or C. elegans
extract, the Oct-1 POU domain, but not VP16, bound DNA on
its own (Fig. 1, cf. lanes 1 to 3). Together, the Oct-1 POU
domain and VP16 formed a low level of HCF-independent
VP16-induced complex (Fig. 1, lane 4). Addition of purified
human HCF (lane 5) did not result in any new complexes,
whereas addition of the C. elegans extract alone resulted in a
low level of a novel complex (lane 6), for which we do not know
the identity. Addition of human HCF or C. elegans extract to
either the Oct-1 POU domain or VP16 resulted in superimpo-
sition of the individual patterns of complex formation (Fig. 1,
cf. lanes 2 and 3 and lanes 5 to 10). However, addition of either
the human HCF preparation or the C. elegans extract together
with VP16 to the Oct-1 POU domain induced novel VP16-
induced complexes (cf. lanes 11 and 12 with lanes 7 and 8).
These results suggest that C. elegans worms contain an activity
that can replace human HCF in stabilizing the VP16-induced
complex.
The mobility of the C. elegans VP16-induced complex (Ce
VIC) is between that of the HCF-independent VP16-induced
complex and that of the human HCF VP16-induced complex
(Hu VIC) (Fig. 1), suggesting that a C. elegans protein of a
different size from that of human HCF, probably smaller, is
incorporated into the C. elegans VP16-induced complex. A
similar analysis of insect extracts suggested that insect HCFs
are also smaller than human HCF (31); direct comparison of
VP16-induced complexes stabilized by insect and C. elegans
extracts suggests that the C. elegans HCF-like protein is smaller
than its insect counterparts (28a).
Functional C. elegans HCF homolog. The surprising finding
that invertebrate cell extracts can stabilize association of a viral
protein with a human transcription factor (i.e., VP16 with
FIG. 1. Extract from the nematode C. elegans can stabilize a VP16-induced
complex. Partially purified human HCF and cell extract from mixed-stage C.
elegans were assayed for VP16-induced complex formation by using an electro-
phoretic mobility retardation assay with bacterially expressed Oct-1 POU do-
main (Oct-1 POU), GST-VP16DC fusion protein (VP16), and labeled HSV
(OCTA1)TAATGARAT probes. Results obtained with probe alone (lane 1)
and with probes with the Oct-1 POU domain (lane 2), GST-VP16 (lane 3), and
the Oct-1 POU domain and GST-VP16 (lane 4) are shown. Purified human HCF
or 2 mg of C. elegans cell extract was assayed with probe alone (lanes 5 and 6) and
with probes with the Oct-1 POU domain (lanes 7 and 8), GST-VP16 (lanes 9 and
10), and the Oct-1 POU domain and GST-VP16 (lanes 11 and 12). The positions
of the free probe, the Oct-1 POU domain-DNA complex, and the VP16-induced
complexes from human (Hu VIC) and C. elegans (Ce VIC) extracts are indicated.
The asterisk indicates the position of an HCF-independent VP16-induced com-
plex.
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Oct-1) (this study and references 14 and 31), prompted us to
search the C. elegans genome sequence for human HCFVIC
domain-related sequences. This search, however, was ham-
pered by the general similarity of the HCFVIC domain to kelch
repeat-containing proteins. For example, in our first attempt to
identify a C. elegans HCF homolog, we identified sequence
similarity to the predicted C. elegans gene F33C8.1 (Q19981),
a kelch repeat-containing gene. The product of this gene, how-
ever, failed to stabilize the VP16-induced complex (data not
shown).
Subsequent determination of the C. elegans genome se-
quence revealed a sequence on C. elegans chromosome IV
which was related to both the amino- and carboxy-terminal
regions of human HCF. This sequence similarity has also been
noted by others (13, 17). The predicted coding sequence for
this gene presented in the database and reproduced in these
published studies (13, 17) does not, however, reveal similarity
to the entire region of human HCF that is required for stabi-
lization of the VP16-induced complex (i.e., the HCFVIC do-
main) (33). Further examination of the C. elegans genomic
sequence neighboring this gene revealed possible exons that
would provide similarity to the entire human HCFVIC domain.
Encouraged by this observation, we designed primers that we
predicted would match the translational initiation and stop
codons of the C. elegans HCF gene and used them for PCR
with a C. elegans cDNA library. A cDNA thus isolated revealed
sequence similarity to the human HCF gene across the entire
HCFVIC domain-coding sequences. Further PCR analysis
showed that the transcript from this gene contains a trans-
spliced SL1 leader sequence positioned five nucleotides up-
stream of the predicted initiation codon (data not shown).
Figure 2 shows a comparison of the amino-acid sequence of
this C. elegans HCF-related protein with that of human HCF.
In contrast to human HCF, which is approximately 2,000
amino acids long, the predicted C. elegans protein contains
only 782 amino acids, in which the amino- and carboxy-termi-
nal regions of human HCF are highly conserved. As illustrated
in Fig. 2B, the amino-terminal HCFVIC domain of human HCF
is 54% identical to the corresponding region of the C. elegans
HCF-related protein and the carboxy-terminal 230 amino acids
of human HCF are 49% identical to the carboxy-terminal re-
gion of the C. elegans protein (see also Fig. 2A). The remaining
central 136 amino acids of the C. elegans protein share less
similarity to human HCF, displaying only little, if any, similar-
FIG. 2. C. elegans HCF displays uneven sequence similarity to human HCF. (A) Amino acid sequence alignment of C. elegans HCF with corresponding regions of
human HCF. Dots represent positions of identity between human HCF and C. elegans HCF sequences. The limits of the six HCFKEL repeats (33) are indicated in
brackets. The conserved proline residue (P145 in C. elegans HCF and P134 in human HCF) that is mutated in tsBN67 HCF (8) is indicated by the arrow. (B) Schematic
structure comparison of human and C. elegans HCFs. The schematic representation of human HCF is as shown previously (30). Conservation represents the percentages
of identical residues between C. elegans and human HCF in the regions indicated. Charged/WYF, region enriched in charged and large hydrophobic residues.
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ity to the basic and acidic regions in human HCF. Significantly,
as noted previously (13, 17), this C. elegans protein contains no
evident similarity to the human HCFPRO repeats required for
HCF processing in human cells (32). This comparison suggests
that, if this protein is the functional C. elegans homolog of
human HCF, C. elegans HCF either is not processed or is
processed by a different mechanism.
To determine whether the C. elegans HCF-related protein is
functionally related to human HCF, we assayed the ability of
this protein to stabilize the VP16-induced complex by using an
electrophoretic mobility retardation assay as shown in Fig. 3.
To compare the activities of the human and C. elegans proteins,
we synthesized the HCFVIC domain of human HCF and the
full-length HCF protein and putative HCFVIC domain of C.
elegans by in vitro translation. The in vitro translation extract
used for this experiment generated a low level of contaminat-
ing complex in the electrophoretic mobility retardation assay
(Fig. 3, cf. lane 3 with lanes 1 and 2). Consistent with previous
results (17, 33), the wild-type human HCFVIC domain (lane 4)
but not the mutant human HCFVIC domain carrying the
tsBN67 P134S mutation (Fig. 3, lane 5) directed formation of
a prominent VP16-induced complex, referred to as Hu mini-
VIC. The full-length C. elegans protein synthesized in vitro also
directed VP16-induced complex formation (Fig. 3, lane 6); this
complex comigrates with the VP16-induced complex generated
by C. elegans extract (data not shown). Sensitivity of the C.
elegans VP16-induced complex to antisera directed against the
amino terminus of the predicted C. elegans protein sequence
(Fig. 3, lane 8) but not to the corresponding preimmune anti-
sera (lane 7) indicates that, as with the human protein, the C.
elegans protein was incorporated into the VP16-induced com-
plex. These results suggest that this C. elegans HCF-related
protein is a functional homolog of human HCF. Following the
convention of the C. elegans research community, we designate
this protein HCF-1 and its cognate gene hcf-1. Here, however,
we refer to HCF-1 as C. elegans HCF or CeHCF.
Consistent with the observed functional relationship be-
tween the C. elegans and human HCF proteins, the proline that
is changed to a serine in the temperature-sensitive tsBN67
mutation is conserved in the C. elegans HCF protein (Fig. 2A).
To determine whether a mutation in C. elegans HCF which is
analogous to the hamster tsBN67 mutation also disrupts VP16-
induced complex formation, we engineered the proline-to-
serine mutation into the corresponding position (residue 145)
of full-length C. elegans HCF (P145S). As in human and ham-
ster HCF (8, 33), this tsBN67 proline-to-serine point mutation
disrupts VP16-induced complex formation (Fig. 3, cf. lanes 9
and 6).
We also assayed the ability of the region of C. elegans HCF
corresponding to the human HCFVIC domain (CeHCF resi-
dues 1 to 395 [CeHCFN395]) to stabilize the VP16-induced
complex. Curiously, although CeHCFN395 stabilized the VP16-
induced complex (Fig. 3, lane 10), it did so less efficiently than
either the human HCFVIC domain or the full-length CeHCF
(Fig. 3, cf. lanes 4, 6, and 10). Thus, the C. elegans HCF region
that contributes to stabilization of the VP16-induced complex
may extend beyond the HCFKEL-repeat region.
Developmental regulation of HCF expression in C. elegans.
Southern hybridization analysis using the cloned C. elegans
hcf-1 cDNA as probe demonstrated that there is a single copy
of the hcf-1 gene in the C. elegans genome (data not shown).
To reveal the expression of hcf-1 during development, worms
were synchronized by embryo isolation and subsequent collec-
tion of worms at the embryonic, L1 to L4 larval, and gravid
FIG. 3. In vitro-translated CeHCF promotes VP16-induced complex forma-
tion. Human and C. elegans HCFs were synthesized in vitro and assayed for HCF
activities by using an electrophoretic mobility retardation assay. Lane 1 contains
probe alone, and lanes 2 to 10 contain probes with the Oct-1 POU domain and
GST-VP16 proteins. Samples contained in addition unprogrammed reticulocyte
lysate (lane 3) and reticulocyte lysates programmed with templates for wild type
(lane 4) or P134S (lane 5) human HCFN380, full-length wild type (lanes 6 to 8),
P145S (lane 9) CeHCF and CeHCFN395 (lane 10). Preimmune serum (lane 7)
and anti-CeHCF antiserum (lane 8) were added to the binding reactions. The
positions of free probe, the Oct-1 POU domain complex, and the VP16-induced
complex with human HCFN380 (Hu mini-VIC) and full-length (Ce VIC) and
amino-terminal (Ce mini-VIC) CeHCFs are indicated. The asterisk indicates a
nonspecific complex generated by the reticulocyte lysate.
FIG. 4. The expression of the hcf-1 gene is developmentally regulated. C.
elegans worms were synchronized as described in Materials and Methods. Total
RNAs were isolated from embryos; L1, L2, L3, and L4 larvae; and adults. RNAs
were probed by Northern hybridization analysis using labeled hcf-1 cDNA as a
probe. The levels of total RNA in each lane were assayed by staining the 18S
rRNA with ethidium bromide as shown at the bottom.
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(embryo-containing adults) developmental stages. Total RNA
was isolated and probed for hcf-1 mRNA expression by North-
ern hybridization analysis as shown in Fig. 4. This analysis
revealed a single hcf-1 mRNA of 2.6 kb expressed primarily in
embryos and adults (Fig. 4, cf. lanes 1 and 6 with the larval
stages in lanes 2 to 5). The embryonic expression parallels the
embryonic expression of human HCF mRNA (13, 29). The
adult expression may represent either adult cell expression
(i.e., somatic or germline) or expression in the embryos present
in gravid adults; we have not distinguished between these pos-
sibilities.
We also assayed the abilities of extracts from C. elegans at
different stages of development to stabilize the VP16-induced
complex. We prepared cell extracts from worms at different
developmental stages and assayed their abilities to support
VP16-induced complex formation by using an electrophoretic
mobility retardation assay as shown in Fig. 5. As with the hcf-1
mRNA, CeHCF activity was observed in extracts from em-
bryos and adult worms (Fig. 5, lanes 3 and 8) but not in extracts
from larvae (lanes 4 to 7). The authenticity of the observed
complex with the embryo extract was confirmed by use of the
antisera directed against the amino terminus of the predicted
C. elegans protein sequence (aHCF) and preimmune antisera
(Fig. 5, lanes 9 and 10), which shows that the predicted amino-
terminal sequence presented in Fig. 2 is correct. Thus, during
C. elegans development, VP16-induced complex-forming activ-
ity correlates with hcf-1 gene expression.
Rescue of the tsBN67 cell proliferation defect by CeHCF.
The studies described above demonstrate that the ability of
HCF to stabilize the VP16-induced complex has been con-
served during metazoan evolution (Fig. 1 and 3). Therefore, we
asked whether the ability of HCF to promote cell proliferation
has also been conserved. A priori, examination of the C. el-
egans HCF sequence would suggest that the C. elegans HCF
protein cannot overcome the hamster tsBN67 cell-prolifera-
tion defect because it lacks sequences corresponding to the
basic region of human HCF (Fig. 2); in human HCF, the basic
region sequences are required to rescue the tsBN67 cell pro-
liferation defect (33). Nevertheless, to test the ability of C.
elegans HCF to promote mammalian cell proliferation, we
transfected tsBN67 cells with mammalian CeHCF expression
vectors and assayed the transfected cells for colony formation
at a nonpermissive temperature as shown in Fig. 6. Analysis of
protein expression in a separate short-term assay showed that
all of the proteins assayed are faithfully expressed (data not
shown).
Full-length human HCF rescued the tsBN67 defect in this
assay (Fig. 6, cf. plates 5 and 1) as described previously (8, 33).
Also consistent with the results of previous studies (33), the
amino-terminal half of human HCF (HuHCFN1011) rescued
the temperature-sensitive cell proliferation defect better than
full-length HCF (Fig. 6, cf. plates 4 and 5), whereas just the
HCFVIC domain (HuHCFN380) lacking the basic region failed
to rescue the defect (cf. plates 1 and 2). To our surprise,
full-length C. elegans HCF complemented the tsBN67 defect
even though it lacks a conserved basic region (cf. plates 1 and
6). Thus, a role for HCF in cell proliferation has been con-
served during metazoan evolution, but interestingly, this role is
not dependent on conservation of a basic region.
Further, to our surprise and in stark contrast to the results
obtained with the human protein, the region of C. elegans HCF
corresponding to the human HCFVIC domain (CeHCFN395)
complemented the tsBN67 defect nearly as well as the full-
length C. elegans HCF protein (Fig. 6, cf. plates 3 and 6) and
better than its human HCFVIC domain counterpart (cf. plates
2 and 3). This result explains why C. elegans HCF can rescue
the tsBN67 defect even though it lacks an evident basic region.
It also suggests that, while the cellular function of HCF has
been conserved during metazoan evolution, the relative roles
of different regions of HCF in promoting cell proliferation
have changed: in human HCF, the HCFVIC domain cooperates
with the neighboring basic region to promote cell proliferation,
whereas in C. elegans, the region corresponding to the human
HCFVIC domain can promote cell proliferation on its own.
DISCUSSION
Through identification and characterization of a functional
homolog of mammalian HCF in C. elegans we have shown that
selected sequences and functions of HCF have been conserved
in metazoans.
Uneven HCF sequence conservation during metazoan evo-
lution. The complete sequence of C. elegans HCF reveals a
striking pattern of sequence conservation: the amino- and car-
boxy-terminal regions of HCF are highly conserved, but as
noted previously (13, 17), the central regions, including the
HCFPRO repeats required for human HCF processing (32), are
poorly conserved (Fig. 2). When the sequence of human HCF
was first identified, there was no known sequence relationship
to other proteins, but it was noted that both the amino-termi-
nal and carboxy-terminal regions are enriched in charged and
FIG. 5. CeHCF activity correlates with hcf-1 gene expression during C. el-
egans development. Total-cell extracts from worms at different developmental
stages were assayed for VP16-induced complex formation by using an electro-
phoretic mobility retardation assay. Lane 1 contains probe alone, and lanes 2 to
10 contain probes with the Oct-1 POU domain and GST-VP16 proteins. Samples
contained in addition extract from embryos (lanes 3, 9, and 10); L1, L2, L3, or L4
larvae (lanes 4 to 7); and adults (lane 8). Preimmune serum (lane 9) and
anti-CeHCF antiserum (lane 10) were added to the binding reaction. The posi-
tions of free probe, the Oct-1 POU domain complex, and the VP16-induced
complex (Ce VIC) are indicated. The asterisk indicates a weak HCF-indepen-
dent VP16-induced complex.
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large hydrophobic residues (Charged/WYF [30]). We now
know that the amino-terminal Charged/WYF region is the
HCFVIC domain (17, 33) and is also involved in cell prolifer-
ation (8). Although implicated in stabilization of a VP16-in-
duced complex with full-length VP16 (17), the cellular function
of the carboxy-terminal Charged/WYF region remains un-
known. Its high level of conservation in C. elegans suggests
that, like its amino-terminal counterpart, it also plays an im-
portant role in HCF function, perhaps also in cell proliferation.
The lack of conservation of the central region of mammalian
HCF in a functional homolog of this protein in C. elegans has
important implications for our understanding of the evolution
of HCF. For example, the lack of HCFPRO repeats in C. el-
egans HCF suggests that in C. elegans HCF processing is not
essential for the function of the conserved amino- and carboxy-
terminal regions of HCF. A priori, we imagined two potential
structures for a functional homolog(s) of HCF in distantly
related species: (i) the HCFPRO repeats and processing would
be conserved, or (ii) the HCFPRO repeats would be lost and the
amino- and carboxy-terminal regions would be encoded by
separate genes. Instead, in C. elegans HCF, the HCFPRO re-
peats have been lost but the amino- and carboxy-terminal re-
gions remain part of a single gene. These results make the
purpose of HCF processing a continuing enigma. We suspect
that mammalian HCF processing and controlled association of
the resulting fragments provide mammalian HCF greater ver-
satility in its cellular function such as in the control of cell
proliferation.
The other region of human HCF of known function but not
conserved in C. elegans HCF is the basic region between the
HCFVIC domain and the HCFPRO repeats (Fig. 2). In human
HCF, the basic region, together with the HCFVIC domain, is
required to rescue the tsBN67 cell proliferation defect (33).
Because of the lack of a corresponding basic region in C.
elegans HCF, we were surprised to find that C. elegans HCF
can rescue the tsBN67 defect. C. elegans HCF rescues the
tsBN67 phenotype because its HCFVIC-like domain is more
potent than its human counterpart in rescuing the tsBN67
phenotype (Fig. 6, panels 2 and 3). Thus, in certain respects,
the distantly related C. elegans HCF protein functions better
than the human protein in mammalian cells. Perhaps, in hu-
man HCF, the HCFVIC domain and the basic region cooperate
to promote cell proliferation, whereas in C. elegans HCF, the
HCFVIC-like region can drive cells through the cell cycle in-
dependently of a basic region. Curiously, however, although
the C. elegans HCFVIC-like region is more potent for rescue of
the tsBN67 cell proliferation defect, it is less effective for sta-
bilization of the VP16-induced complex (Fig. 3). We do not
know the reason for this difference.
The smaller size of C. elegans HCF compared to that of
human HCF demonstrates that HCFs can differ considerably
in size. This flexibility may explain the nature of the C1 and C2
VP16-induced complexes described by Kristie and colleagues
(14) using VP16 purified from Spodoptera cells after baculovi-
rus expression. We suggest that the faster-migrating complex
called C1 in that study contained Spodoptera HCF (or in some
cases possibly amino-terminal fragments of human HCF) and
the C2 complex contained full-length human HCF.
The viral protein VP16 targets a cellular protein that is
highly conserved in metazoans. VP16 is a viral protein of the
human pathogen HSV. Thus, the ability of VP16 to associate
with HCF from animals as distantly related to humans as C.
elegans probably results because VP16 binds to a surface of
HCF that is used in a cellular function conserved during meta-
zoan evolution. We hypothesize that this conserved cellular
function of HCF is its association with the basic leucine zipper
protein, LZIP. LZIP, also known as Luman (19), binds HCF as
VP16 does, and LZIP and VP16 share a tetrapeptide motif
FIG. 6. CeHCF rescues the hamster tsBN67 cell proliferation defect. Hamster tsBN67 cells were transfected with the human pCGNHCF or C. elegans pCGNCe-
HCF HCF expression construct as described in Materials and Methods. Plate 1, pCGN vector alone; plate 2, pCGNHCFN380; plate 3, pCGNCeHCFN395; plate 4,
pCGNHCFN1011; plate 5, pCGNHCFFL; plate 6, pCGNCeHCFFL. Following the transfection protocol, the cells were incubated at 39.5°C in the presence of G418 for
2 weeks. The colonies were then fixed and stained with crystal violet.
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(E/DHxY) that directs association with HCF (7, 20). Like HCF,
LZIP has been conserved during metazoan evolution. In Dro-
sophila melanogaster, the LZIP homolog is BBF-2/dCREB-A
(1, 24), which also possesses an E/DHxY motif that directs
association with HCF (7, 20). Thus, in its association with
HCF, VP16 probably mimics how LZIP binds HCF. Together
with the studies described here, these observations suggest that
C. elegans probably also possesses a functional LZIP homolog,
although its identity has yet to be determined.
In contrast to the high level of conservation of the HCF
surface that directs association with VP16, the surface of Oct-1
that directs association with VP16 has not been highly con-
served. Indeed, owing to differences on the VP16-interaction
surface of the mouse Oct-1 homeodomain, VP16 fails to asso-
ciate effectively with mouse Oct-1 (6, 27). Thus, apparently the
VP16-interaction surface of Oct-1 is less important for Oct-1
cellular function than the VP16-interaction surface of HCF is
for HCF cellular function. Consistent with this hypothesis,
VP16 is not known to mimic a cellular factor in its interaction
with Oct-1. Indeed, just the opposite, a cellular factor that is
known to interact with the Oct-1 homeodomain, the B-cell
Oct-1 coregulator OCA-B (9, 21, 25), interacts with a different
surface of the Oct-1 homeodomain than does VP16 (3).
VP16 targets a conserved cell proliferation function to con-
trol HSV infection. One of the curiosities of HSV infection is
that the viral transactivator VP16 requires association with two
cellular proteins to activate viral gene expression. We have
hypothesized that the requirement for productive association
with cellular proteins serves as a checkpoint to gauge whether
the state of the infected cell is appropriate for productive lytic
infection (30). The results described here suggest that, in its
association with HCF, VP16 targets a protein with an ancient
role in cell proliferation. This association may serve as a mech-
anism to link HSV infection to the cell cycle status of the
infected cell.
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